Agios Pharmac

AGIO

Agios Pharmac (AGIO)

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead pr...

Open
--
High
--
Low
--
Prev. Close
--
Volume
--
Turnover
--
Avg Price
--
Bid/Ask Ratio
--
Amplitude
--
52wk High
--
Volume Ratio
--
Turnover Ratio
--
52wk Low
--
Float Mkt Cap
--
Market Cap
--
P/ETTM
--
P/EDynamic
--
P/EStatic
--
EPSTTM
--
EPSDynamic
--
EPSStatic
--
BVPS
--
P/B
--
Circulating Supply
--
Dividend YieldTTM
--
DividendTTM
--
Shares
--
Min lot size
--
Currency
--

Agios Pharmac Analyst Rating

View more

Forecast & Rating

Oct 29, 2026
Price forecast
$45.8847.04%
Forecast & RatingBuy
10analysts
  • Strong buy70.00%
  • Buy0.00%
  • Hold30.00%
  • Sell0.00%
  • Strong sell0.00%

Bullish vs. Bearish — Last 3 Months

182 followers · 0 opinions
▲Bullish50%
50%Bearish▼
  • N
    Nancy Pelosi Tracker

    New: Gil Cisneros (D) just filed up to $1,300,000 of new stock trades

    The ones that stood out are 3 pharma picks: $Agios Pharmac(AGIO.US), $Bridgebio Pharma(BBIO.US), and $Ultragenyx Pharma(RARE.US)

    The crazy part is that all 3 had major FDA decisions go their way within weeks. every stock is up 10-26%

    Cisneros doesn't sit on a single health committee but 3/3 on FDA decisions is pretty good

    图片 1,共 1 张